Medicate International Private Limited

Medicate International Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U74140DL2015PTC280215 Incorporated 14 May 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.74 Cr
▼ 36.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Last financials
Mar 2024
Balance sheet date

About Medicate International Private Limited

Data last updated: 05 January 2026

Medicate International Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 14 May 2015, the company has been in operation for over 11 years.

Registered with ROC Delhi under CIN U74140DL2015PTC280215.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Laxmi and Ashwini Tripathi.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2024. Office: House No 3013/2 – A Khasra No 69 G Floor Gali No – 19 Ranjit Nagar, New Delhi, Delhi, India – 110008.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.74 Cr, a decline of 36% compared to the previous year.

The company is associated with 1 brand - Medicate Pharma. As per MCA filings, the company has open charges of ₹1 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicatepharma.com.

Company Details of Medicate International Private Limited
CIN U74140DL2015PTC280215
Registration Number 280215
Incorporation Date 14 May 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    House No 3013/2 – A Khasra No 69 G Floor Gali No – 19 Ranjit Nagar, New Delhi, Delhi, India – 110008
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Medicate International Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Medicate International Private Limited report

Financials, compliance, directors, charges, ownership and filings for Medicate International Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Medicate International Private Limited

Medicate International Private Limited operates one associated brand: Medicate Pharma. These brands represent Medicate International Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Distributes a wide range of diversified pharmaceutical drugs. medicatepharma.com

Competitors & Alternatives of Medicate International Private Limited

Brands and companies operating in the same space as Medicate International Private Limited include Entero Healthcare, AmerisourceBergen, Keimed and 3 more.

Competitor Description Location Founded
Entero Healthcare Entero Healthcare India's leading healthcare products distribution platform Mumbai, India, India 2018
AmerisourceBergen AmerisourceBergen Pharmaceutical distribution and supply chain services are provided globally. Chesterbrook, United States, United States 1985
Keimed Keimed Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. Hyderabad, India, India 2000
Sandor Medicaids Sandor Medicaids Provider of medical equipment, devices, and drugs distribution services Hyderabad, India, India 1995
Dipna Pharmachem Dipna Pharmachem Distributor of pharmaceutical raw materials Ahmedabad, India, India 2011
Mahaveer Medi Sales Mahaveer Medi Sales Serves as a distributor of a wide range of pharmaceutical drugs. Bengaluru, India, India 2016

Business Activity of Medicate International Private Limited

Medicate International Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Medicate International Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Medicate International Private Limited

Medicate International Private Limited is audited by VINEET SANDESH & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
VINEET SANDESH & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Medicate International Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Medicate International Private Limited

Medicate International Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Laxmi Director 14 May 2015 11 Years 2 Months Current
Ashwini Tripathi Director 14 May 2015 11 Years 2 Months Current

Financials of Medicate International Private Limited FY 2024 filings available

Medicate International Private Limited reported revenue of ₹1.74 Cr (down 36.00% YoY) for FY 2024.

Revenue · FY 2024
₹1.74 Cr ▼ 36.00%
Premium access

Ten-year financial statements for Medicate International Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Medicate International Private Limited

Premium access

Shareholding and ownership data for Medicate International Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Medicate International Private Limited

Open charges
₹1 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹1.00 Cr
Latest charge details
DateLenderAmountStatus
05 Jun 2017 Others ₹1 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Medicate International Private Limited

View historical data on people associated with Medicate International Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Medicate International Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Medicate International Private Limited

Premium access

GST registrations and filing compliance for Medicate International Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Medicate International Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Medicate International Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Medicate International Private Limited

Premium access

MSME payment history for Medicate International Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Medicate International Private Limited

Premium access

Corporate group structure for Medicate International Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Medicate International Private Limited

Premium access

MCA filings and documents for Medicate International Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Medicate International Private Limited

Activity
30 Sep 2025
Medicate International Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2024
Medicate International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
05 Jun 2017
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100102566 was registered on 05 Jun 2017.
Directors
14 May 2015
Laxmi was appointed as a Director on 14 May 2015 & has been associated with this company since 11 years 2 months.
Directors
14 May 2015
Ashwini Tripathi was appointed as a Director on 14 May 2015 & has been associated with this company since 11 years 2 months.
Activity
14 May 2015
Medicate International Private Limited was registered on 14 May 2015 with Roc Delhi & aged 11 years 2 months as per MCA records.

Frequently Asked Questions about Medicate International Private Limited

Medicate International Private Limited is an active private limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 14 May 2015 (11+ years old) and is registered under CIN U74140DL2015PTC280215.

Medicate International Private Limited reported revenue of ₹1.74 Cr for FY 2024 (down 36.00% YoY).

The current directors of Medicate International Private Limited are:

The primary industry of Medicate International Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Medicate International Private Limited can be reached at the registered office: House No 30132 – A Khasra No 69 G Floor Gali No – 19 Ranjit Nagar, New Delhi, Delhi, India – 110008, or through the website medicatepharma.com.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹10 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available